F10 and interstitial lung disease: Patients who received both amiodarone and FXa inhibitors had the highest risk of incident ILD, whereas those treated with warfarin but without amiodarone had the lowest risk of incident ILD (0.38 vs 0.13 per 100 patient-years; HR, 2.69 [95% CI, 1.88-3.85]; P < .001) (eFigure 4 in the Supplement).